Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06379126

The Diagnostic and Prognostic Value of TAT, PIC, tPAI·C and TM in Sepsis-induced Coagulopathy

Sponsor: The First Hospital of Jilin University

View on ClinicalTrials.gov

Summary

In order to evaluate the diagnostic and prognostic value of thrombin-antithrombin complex(TAT), α2-plasmin inhibitor-plasmin complex(PIC), tissue plasminogen activator-inhibitor complex(tPAI·C) and thrombomodulin(TM) in sepsis-induced coagulopathy(SIC), hospitalized patients with sepsis were prospectively included. Plasma TAT, PIC, tPAI·C,TM levels within 24 h after sepsis diagnosis were detected by MCL60 chemiluminescence analyzer. According to the SIC score (≥4), they were divided into SIC group and non-SIC group, and ROC curve analysis was performed according to the biomarker test results.

Official title: The Diagnostic and Prognostic Value of Thrombin-Antithrombin Complex(TAT), α2-plasmin Inhibitor-plasmin Complex(PIC), Tissue Plasminogen Activator-inhibitor Complex(tPAI·C) and Thrombomodulin(TM) in Sepsis-induced Coagulopathy

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

210

Start Date

2024-04-20

Completion Date

2026-04-20

Last Updated

2024-04-23

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Test thrombin-antithrombin complex(TAT), α2-plasmin inhibitor-plasmin complex(PIC), tissue plasminogen activator-inhibitor complex(tPAI·C) and thrombomodulin(TM)

Test TAT, PIC, tPAI·C and TM of blood of SIC patients.